MXPA05005046A - Formulaciones parasiticidas topicas y metodos de tratamiento. - Google Patents

Formulaciones parasiticidas topicas y metodos de tratamiento.

Info

Publication number
MXPA05005046A
MXPA05005046A MXPA05005046A MXPA05005046A MXPA05005046A MX PA05005046 A MXPA05005046 A MX PA05005046A MX PA05005046 A MXPA05005046 A MX PA05005046A MX PA05005046 A MXPA05005046 A MX PA05005046A MX PA05005046 A MXPA05005046 A MX PA05005046A
Authority
MX
Mexico
Prior art keywords
methods
livestock
formulations
water
treatment
Prior art date
Application number
MXPA05005046A
Other languages
English (en)
Inventor
Stanley Shepherd
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of MXPA05005046A publication Critical patent/MXPA05005046A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a formulaciones micelares acuosas para la administracion topica de bencimidazoles o salicilanilidas con lactonas macrociclicas a ganado para el control de endo y ectoparasitos, las cuales comprenden un primer agente activo seleccionado de bencimidazoles insolubles en agua, salicilanilidas y derivados activos o sales del mismo, en combinacion con un segundo agente activo seleccionado de lactonas macrociclicas o derivados activos o sales de las mismas, y tambien comprende, por litro de formulacion: alrededor de 100 g a aproximadamente 400 g de agente(s) tensioactivos(s) veterinariamente aceptables; alrededor de 200 g a aproximadamente 750 g de solvente(s) miscible(s) en agua aceptable(s) desde el punto de vista veterinario; y alrededor de 50 g a aproximadamente 350 g de agua, asi como metodos para administrar al ganado dichas formulaciones, y metodos para controlar y/o prevenir enfermedades o infeccion parasitaria in el ganado.
MXPA05005046A 2002-11-11 2003-11-11 Formulaciones parasiticidas topicas y metodos de tratamiento. MXPA05005046A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952597A AU2002952597A0 (en) 2002-11-11 2002-11-11 Topical parasiticide formulations and methods of treatment
PCT/AU2003/001490 WO2004043445A1 (en) 2002-11-11 2003-11-11 Topical parasiticide formulations and methods of treatment

Publications (1)

Publication Number Publication Date
MXPA05005046A true MXPA05005046A (es) 2005-11-17

Family

ID=28795986

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005046A MXPA05005046A (es) 2002-11-11 2003-11-11 Formulaciones parasiticidas topicas y metodos de tratamiento.

Country Status (14)

Country Link
US (1) US20060121072A1 (es)
EP (1) EP1560572A4 (es)
JP (3) JP4643990B2 (es)
KR (1) KR20050090385A (es)
AR (1) AR041936A1 (es)
AU (1) AU2002952597A0 (es)
BR (1) BR0316187A (es)
CA (1) CA2504197A1 (es)
MX (1) MXPA05005046A (es)
NZ (1) NZ540589A (es)
PE (1) PE20040545A1 (es)
TW (1) TWI314848B (es)
WO (1) WO2004043445A1 (es)
ZA (1) ZA200503758B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7666444B2 (en) 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
ATE466578T1 (de) * 2004-02-03 2010-05-15 Wyeth Llc Wurmmittel
CA2566084C (en) * 2004-06-07 2014-01-21 Syngenta Participations Ag Methods of reducing nematode damage
WO2006061214A1 (en) * 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
JP2009508853A (ja) 2005-09-15 2009-03-05 メリアル リミテッド 駆虫製剤
ES2527120T3 (es) * 2005-12-06 2015-01-20 Zoetis W Llc Composiciones no acuosas de bencimidazol
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
AU2008329706B2 (en) * 2007-11-26 2013-01-10 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
ES2617672T3 (es) 2008-10-08 2017-06-19 Zoetis Services Llc Composiciones antihelmínticas de bencimidazol
WO2011048040A1 (en) * 2009-10-19 2011-04-28 Intervet International B.V. Method and formulation for the control of parasites
PL2568980T3 (pl) * 2010-05-12 2016-05-31 Merial Inc Pasożytobójcze preparaty lewamizolu i laktonów makrocyklicznych do wstrzykiwania
US11166912B2 (en) 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
KR101855989B1 (ko) 2016-12-23 2018-05-09 강원대학교산학협력단 가용화제를 첨가한 물을 추출용매로 이용한 유용성분이 증가된 메밀 종자 추출물의 제조 방법 및 그에 따른 메밀 종자 추출물
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
US3989826A (en) * 1972-05-12 1976-11-02 Ici Australia Limited Method of killing internal parasites using salicylanilides
US3927071A (en) * 1972-05-12 1975-12-16 Ici Australia Ltd Salicylanilides
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4336262A (en) * 1973-02-23 1982-06-22 Fisons Ltd. Pour-on veterinary anthelmintic
GB1493375A (en) * 1974-09-20 1977-11-30 Ici Ltd Salicylanilide derivatives
US4005218A (en) * 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
DE3029426A1 (de) * 1980-08-02 1982-03-11 Bayer Ag, 5090 Leverkusen Gegen zwecken wirksame pour-on-formulierungen
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
US4607050A (en) * 1981-10-19 1986-08-19 Wellcome Australia Limited Method of controlling insects and parasites with an aqueous localized pour-on formulation
NZ203574A (en) * 1982-03-16 1986-04-11 Wellcome Australia Pour on compositions containing pyrethroids and thiazoles
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
GB8723347D0 (en) * 1987-10-05 1987-11-11 Shell Int Research Ectoparasiticidal pour-on formulation
US5639949A (en) * 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
NZ266408A (en) * 1993-05-26 1997-09-22 Commw Scient Ind Res Org Antiparasitic, oral particulate composition for ruminants
DK72593D0 (da) * 1993-06-18 1993-06-18 Symbicom Ab Rekombinant protein
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
US6010710A (en) * 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
FR2755824B1 (fr) * 1996-11-19 1999-01-08 Virbac Sa Formulation galenique des benzimidazoles a usage topique, son procede de preparation et ses utilisations
CN1069032C (zh) * 1997-03-27 2001-08-01 中国农业大学 一种含阿维菌素/依维菌素的兽用抗寄生虫药
US5968990A (en) * 1997-10-14 1999-10-19 Isp Investments Inc. Water-dilutable, microemulsion concentrate and pour-on formulations thereof
AUPP105497A0 (en) * 1997-12-19 1998-01-15 Schering-Plough Animal Health Limited Aqueous insecticidal pour-on treatment
CN1214909A (zh) * 1998-05-14 1999-04-28 王玉万 一种复方兽用抗寄生虫药
US6103248A (en) * 1998-05-22 2000-08-15 Burkhart; Craig G. Topical preparation and therapy for head lice
ATE404172T1 (de) * 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
AR035550A1 (es) * 1999-06-04 2004-06-16 Nufarm Ltd Composiciones estables biocidas
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
EP1129713A1 (en) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Veterinary compositions for the treatment of parasitic diseases
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition

Also Published As

Publication number Publication date
AR041936A1 (es) 2005-06-01
TW200423871A (en) 2004-11-16
WO2004043445A1 (en) 2004-05-27
TWI314848B (en) 2009-09-21
JP4643990B2 (ja) 2011-03-02
BR0316187A (pt) 2005-09-27
KR20050090385A (ko) 2005-09-13
JP2007008963A (ja) 2007-01-18
JP2006508108A (ja) 2006-03-09
NZ540589A (en) 2008-03-28
AU2002952597A0 (en) 2002-11-28
ZA200503758B (en) 2006-11-29
CA2504197A1 (en) 2004-05-27
JP2011105765A (ja) 2011-06-02
PE20040545A1 (es) 2004-08-28
US20060121072A1 (en) 2006-06-08
EP1560572A4 (en) 2011-05-04
EP1560572A1 (en) 2005-08-10

Similar Documents

Publication Publication Date Title
MXPA05005046A (es) Formulaciones parasiticidas topicas y metodos de tratamiento.
ES2620413T3 (es) Formulaciones veterinarias antihelmínticas tópicas
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
KR101864799B1 (ko) 이버멕틴을 사용한 구진농포성 주사의 치료
PT109395B (pt) Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
MXPA05000172A (es) Pastas veterinarias homogeneas, orales, antihelminticas.
DE60023465D1 (de) Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
WO2005011655A3 (en) Pyridazine derivatives and their use as therapeutic agents
RS20060479A (en) Novel compositions for topical delivery
AR057319A1 (es) Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente
TWI433691B (zh) 苯并咪唑之非水性組合物
NO20052408L (no) Farmasoytisk formulering av olanzapin
ES2319626T3 (es) Farmaco para el tratamiento de enfermedades tumorales y de la piel virales.
KR20070107806A (ko) 세르타코나졸, 및 하이드로코르티손 및/또는 항박테리아퀴놀린 화합물을 포함하는 항진균 조성물
ES2846820T3 (es) Composición de lactonas macrocíclicas, levamisol, un aminoazúcar y un agente antiparasitario adicional
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
AR046146A1 (es) Formulaciones farmaceuticas transdermicas para pulverizacion que comprenden un agente activo, un copolimero de vp/va y un vehiculo no acuoso
WO2003026570A3 (en) Reduced toxicity cisplatin formulations and methods for using the same
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
AU2003275779B2 (en) Topical parasiticide formulations and methods of treatment
TH78317B (th) สารผสมตามสูตรฆ่าปรสิตเฉพาะที่และวิธีของการรักษา
TH78317A (th) สารผสมตามสูตรฆ่าปรสิตเฉพาะที่และวิธีของการรักษา
MXPA99005235A (es) Composicion antibacteriana oral veterinaria de fluoroquinolona para duracion extendida de terapia ymetodo de tratamiento.

Legal Events

Date Code Title Description
FG Grant or registration